Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2012072510398N1Phase 3Completed
Phase 3, single-arm trial of omeprazole in gastroesophageal reflux disease (GERD), sponsored by Chemical Injuries Research Center. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2012072510398N1.